Anthony, R M <br/><br/>
Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  06 2017 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00258-17  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amidohydrolases--genetics<br/>Antitubercular Agents<br/>Humans<br/>Microbial Sensitivity Tests<br/>Mutation<br/>Mycobacterium tuberculosis<br/>Pyrazinamide<br/>Tuberculosis, Multidrug-Resistant